Max Healthcare Institute Limited announced that its Nomination and Remuneration Committee (NRC) approved the grant of 50,000 stock options on March 17, 2026. These options are issued under the Employee Stock Option Scheme 2022 (‘MHIL ESOP – 2022’). Each option is convertible into one fully paid-up equity share with a face value of ₹10. The exercise price has been fixed at ₹900 per option, subject to vesting conditions.
Grant of Stock Options Approved
Max Healthcare Institute Limited today confirmed that the Nomination and Remuneration Committee (NRC) met on March 17, 2026, and sanctioned the issuance of stock options to an eligible employee under the company’s Employee Stock Option Scheme 2022 (‘MHIL ESOP – 2022’).
The committee meeting commenced at 9:05 am (IST) and concluded at 9:40 am (IST), formalizing the decision to grant 50,000 stock options.
Key Details of the Grant
The grant details, as summarized in the annexure to the disclosure, include the following primary terms:
- Total Options Granted: 50,000 equity shares, where each option converts into one equity share with a face value of ₹10.
- Exercise Price: The pricing formula sets the Grant Price at ₹900 per stock option.
- Vesting Schedule: Options are subject to pre-vesting conditions and will vest no earlier than 1 (one) year and no later than 5 (five) years from the date of the grant, as determined by the NRC.
- Exercise Window: Once vested, options may be exercised within 3 (three) years from the respective vesting date.
Governance and Administration
The terms and conditions governing these stock options are administered and implemented exclusively by the Nomination and Remuneration Committee of Max Healthcare Institute Limited, adhering to the MHIL ESOP – 2022 framework. The disclosure confirms that the scheme aligns with the relevant regulations, being applicable under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
No variations of the terms of options or subsequent cancellations that would affect the grant details were noted at the time of this announcement, making the item ‘Not applicable’ for variations or lapses.
Source: BSE
